drugset / Trial / NCT02251197
Safety and Tolerability of BIII 890 in Patients With Acute Ischemic Stroke
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective of this study is to assess the safety, tolerability and pharmacokinetic characteristics of BIII 890 after intravenous infusion in acute ischemic stroke patients.
Timeline
- Start
- 2001-07
- Primary completion
- 2002-10
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Crobenetine | Small molecule | — | Intravenous |